J. J. Smith

MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment

Brian D. Griffith, M. D'Angelica, S. Turcotte, 2022, Cancers.

A Medium-Throughput Single Cell CRISPR-Cas9 Assay to Assess Gene Essentiality

J. Moore, R. Copeland, A. Grassian, 2015, Biological Procedures Online.

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

G. Mills, M. Dowsett, H. Gómez, 2012, Nature Medicine.

Regulation of metastasis in colorectal adenocarcinoma: a collision between development and tumor biology.

P. Dhawan, N. Deane, R. Beauchamp, 2008, Surgery.

Identification of a First-in-Class PRMT5 Inhibitor with Potent in Vitro and in Vivo Activity in Preclinical Models of Mantle Cell Lymphoma

Lei Jin, R. Copeland, Elayne Penebre, 2014 .

MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling

S. Batra, P. Dhawan, R. Ahmad, 2018, Molecular Cancer.

EZH2 Inhibitor EPZ-6438 Synergizes With Anti-Lymphoma Therapies In Preclinical Models

Tim J. Wigle, R. Copeland, R. Pollock, 2013 .